ERBB2 and neoplasm: In this study, we conducted transcriptomic profiling on 285 tissue samples, pretreatment biopsies (2 per tumor) and residual tumors, from 129 patients, along with ERBB2 FISH and profiling of the immune microenvironment using NanoString digital spatial profiling.